2 results
Approved WMOPending
The objective of this study is to assess the safety and efficacy of the Veniti Vici* Venous Stent System in achieving patency of the target venous lesion through 36 months in patients who present with clinically significant chronic non-malignant…
Approved WMOCompleted
Primary Objective:- To assess the efficacy of escalating doses of ANF-RHO versus Neulasta in the duration of neutropenia grade 1 or worse (absolute neutrophil count [ANC] * 2.0 x 109/L) in the first chemotherapy cycle (21-day cycle FE100C).Secondary…